Literature DB >> 17709916

Association of plasma adiponectin levels with oxidative stress in hemodialysis patients.

Paik-Seong Lim1, Shun-Liang Chen, Ming-Ying Wu, Chuen-Yuh Hu, Tsai-Kun Wu.   

Abstract

BACKGROUND: Recent evidence suggests that oxidative stress may be an instigator of the metabolic syndrome, and adiponectin, an adipocyte-derived polypeptide, may modulate oxidative stress, ameliorating the atherosclerotic process. AIM: Oxidative stress is increased in hemodialysis (HD) patients. We hypothesize that a relationship between plasma levels of adiponectin and markers of inflammation and oxidative stress exists. METHODS AND
RESULTS: In 124 HD patients, plasma adiponectin levels and three separate oxidative stress markers, tumor necrosis factor-alpha as well as high-sensitivity C-reactive protein (hsCRP) were determined. Plasma adiponectin was significantly and negatively correlated with serum hsCRP (r = -0.247, p = 0.008) and plasma malondialdehyde (MDA) levels (r = -0.326; p < 0.001). Multiple regression analyses suggested that plasma MDA, serum HDL cholesterol levels and logarithmically transformed hsCRP were the variables independently associated with plasma adiponectin levels.
CONCLUSION: Plasma adiponectin was significantly associated with plasma MDA, serum HDL cholesterol levels and serum hsCRP levels. Our results suggest the possibility that plasma adiponectin may play a role in alleviating oxidative stress in HD patients. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709916     DOI: 10.1159/000107509

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

1.  Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease.

Authors:  Cosmina Ioana Bondor; Alina Ramona Potra; Diana Moldovan; Crina Claudia Rusu; Mariana Ciorba Pop; Adriana Muresan; Dan Stefan Vladutiu; Ina Maria Kacso
Journal:  Int Urol Nephrol       Date:  2015-05-14       Impact factor: 2.370

2.  Obesity, diabetes and survival in maintenance hemodialysis patients.

Authors:  Serpil M Deger; Charles D Ellis; Ahuia Bian; Ayumi Shintani; T Alp Ikizler; Adriana M Hung
Journal:  Ren Fail       Date:  2014-01-28       Impact factor: 2.606

3.  Comorbidity burden may explain adiponectin's paradox as a marker of increased mortality risk in hemodialysis patients.

Authors:  Ilia Beberashvili; Tamar Cohen-Cesla; Amin Khatib; Ramzia Abu Hamad; Ada Azar; Kobi Stav; Shai Efrati
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

4.  Effect of Oxidative Stress in Hemodialysed Patients.

Authors:  Attila Peti; Botond Csiky; Eszter Guth; Peter Kenyeres; Emese Mezosi; Gabor L Kovacs; Laszlo Bajnok
Journal:  EJIFCC       Date:  2011-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.